初始化医疗报告生成项目，添加核心代码文件
This commit is contained in:
438
backend/template_explanations.json
Normal file
438
backend/template_explanations.json
Normal file
@@ -0,0 +1,438 @@
|
||||
{
|
||||
"COLOR": {
|
||||
"clinical_en": "Reflects the appearance and properties of urine, assisting in judging the health status of the urinary system and the body as a whole. Normal urine is pale yellow to dark yellow due to containing urobilin and other substances, and is affected by water intake, food, drugs, etc.",
|
||||
"clinical_cn": "反映尿液的外观性状，辅助判断泌尿系统及身体整体健康状态，正常尿液因含尿色素等呈淡黄色至深黄色，受饮水、食物、药物等影响。"
|
||||
},
|
||||
"PH": {
|
||||
"clinical_en": "Reflects the acidity and alkalinity of urine, affected by diet, diseases, drugs, etc., helping to judge acid - base balance, urinary system diseases, and the impact of drugs. The normal urine pH is approximately 4.5 - 8.0, and the fluctuation is related to diet. For example, a diet rich in meat makes it more acidic, and a diet rich in vegetables makes it more alkaline.",
|
||||
"clinical_cn": "反映尿液的酸碱性，受饮食、疾病、药物等影响，帮助判断酸碱平衡、泌尿系统疾病及药物影响等情况。正常尿液pH约 4.5 - 8.0，波动与饮食有关，如食肉多偏酸，食蔬菜多偏碱。"
|
||||
},
|
||||
"TUR": {
|
||||
"clinical_en": "Reflects the clarity and transparency of urine, assisting in judging abnormal components in the urine. Normal urine is clear and transparent, and abnormal turbidity is related to the presence of cells, crystals, bacteria, etc. in the urine.",
|
||||
"clinical_cn": "体现尿液的清澈透明程度，辅助判断尿中成分异常，正常尿液清晰透明，浊度异常与尿中含细胞、结晶、细菌等有关。"
|
||||
},
|
||||
"PRO": {
|
||||
"clinical_en": "Detects the protein content in urine, which is an important indicator for diagnosing kidney diseases and evaluating kidney damage. Normal urine protein is negative or in trace amounts.",
|
||||
"clinical_cn": "检测尿中蛋白质含量，是诊断肾脏疾病、评估肾脏损伤的重要指标，正常尿蛋白阴性或极微量。"
|
||||
},
|
||||
"BLD/ERY": {
|
||||
"clinical_en": "Judges whether there are red blood cells and the destruction of red blood cells in the urine, assisting in the diagnosis of urinary system and systemic diseases. There are very few red blood cells in normal urine, and occult blood is negative.",
|
||||
"clinical_cn": "判断尿中是否有红细胞及红细胞破坏情况，辅助诊断泌尿系统及全身疾病，正常尿中红细胞极少，隐血阴性。"
|
||||
},
|
||||
"GLU": {
|
||||
"clinical_en": "Reflects the glucose content in urine, assisting in the diagnosis of diabetes and other glucose metabolism disorders. Normal urine glucose is negative.",
|
||||
"clinical_cn": "反映尿中葡萄糖含量，辅助诊断糖尿病及其他糖代谢异常疾病，正常尿糖阴性。"
|
||||
},
|
||||
"SG": {
|
||||
"clinical_en": "Reflects the concentration of solutes in urine, reflecting the kidney's concentrating and diluting functions. The normal reference value is approximately 1.003 - 1.030, affected by water intake, sweating, etc.",
|
||||
"clinical_cn": "体现尿液中溶质浓度，反映肾脏浓缩和稀释功能，正常参考值约 1.003 - 1.030，受饮水、出汗等影响。"
|
||||
},
|
||||
"WBC": {
|
||||
"clinical_en": "Reflects the acidity and alkalinity of urine, affected by diet, diseases, drugs, etc., helping to judge acid - base balance, urinary system diseases, and the impact of drugs. The normal urine pH is approximately 4.5 - 8.0, and the fluctuation is related to diet. For example, a diet rich in meat makes it more acidic, and a diet rich in vegetables makes it more alkaline.",
|
||||
"clinical_cn": "反映尿液的酸碱性，受饮食、疾病、药物等影响，帮助判断酸碱平衡、泌尿系统疾病及药物影响等情况。正常尿液pH约 4.5 - 8.0，波动与饮食有关，如食肉多偏酸，食蔬菜多偏碱。"
|
||||
},
|
||||
"NIT": {
|
||||
"clinical_en": "Assists in the diagnosis of urinary system infections, because some bacteria can reduce nitrates in the urine to nitrites. It is normally negative.",
|
||||
"clinical_cn": "辅助诊断泌尿系统感染，因某些细菌可将尿中硝酸盐还原为亚硝酸盐，正常阴性。"
|
||||
},
|
||||
"KET": {
|
||||
"clinical_en": "Reflects the state of fat decomposition and metabolism in the body, assisting in the diagnosis of diseases such as diabetic ketoacidosis. Normal urine ketone bodies are negative.",
|
||||
"clinical_cn": "反映体内脂肪分解代谢情况，辅助诊断糖尿病酮症酸中毒等疾病，正常尿酮体阴性。"
|
||||
},
|
||||
"RBC COUNT": {
|
||||
"clinical_en": "Reflects the total number of red blood cells, is a basic indicator for judging blood diseases such as anemia and erythrocytosis, and is also used to evaluate oxygen - carrying capacity. The normal range for adult males is (4.0 - 5.5) × 10¹²/L, and for adult females is (3.5 - 5.0) × 10¹²/L. 2.",
|
||||
"clinical_cn": "反映红细胞的总体数量，是判断贫血、红细胞增多症等血液疾病的基础指标，也用于评估携氧能力。正常成年男性（4.0-5.5）×10¹²/L，女性（3.5-5.0）×10¹²/L。"
|
||||
},
|
||||
"HB": {
|
||||
"clinical_en": "A key indicator for evaluating anemia and oxygen - carrying capacity, which, together with the number of red blood cells, reflects the oxygen - carrying state of the blood. The normal range for adult males is 120 - 160g/L, and for adult females is 110 - 150g/L. 2.",
|
||||
"clinical_cn": "评估贫血及携氧能力的关键指标，与红细胞数量协同反映血液携氧状态，正常成年男性120-160g/L，女性110-150g/L。"
|
||||
},
|
||||
"HCT": {
|
||||
"clinical_en": "Refers to the percentage of volume occupied by red blood cells in whole blood, reflecting the concentration of red blood cells, assisting in the diagnosis of anemia and erythrocytosis, and also used in the evaluation of dehydration and other conditions. The normal range for adult males is 40% - 50%, and for adult females is 37% - 48%.",
|
||||
"clinical_cn": "指红细胞在全血中所占体积百分比，反映红细胞的浓缩程度，辅助诊断贫血、红细胞增多症，也用于脱水等情况评估，正常成年男性40%-50%，女性37%-48%。"
|
||||
},
|
||||
"MCV": {
|
||||
"clinical_en": "Reflects the average size of red blood cells, helping to classify anemia, such as macrocytic, normocytic, and microcytic anemia. The normal range is 80 - 100fL.",
|
||||
"clinical_cn": "反映红细胞的平均大小，帮助贫血分类，如大细胞性、正细胞性、小细胞性贫血，正常80-100fL。"
|
||||
},
|
||||
"MCH": {
|
||||
"clinical_en": "Indicates the average amount of hemoglobin contained in each red blood cell, assisting in the diagnosis and classification of anemia. The normal range is 27 - 34pg.",
|
||||
"clinical_cn": "表示每个红细胞内平均所含血红蛋白的量，辅助贫血诊断与分类，正常27-34pg。"
|
||||
},
|
||||
"MCHC": {
|
||||
"clinical_en": "Reflects the concentration of hemoglobin in red blood cells, used for anemia classification. The normal range is 320 - 360g/L.",
|
||||
"clinical_cn": "反映红细胞内血红蛋白的浓度，用于贫血分类，正常320-360g/L。"
|
||||
},
|
||||
"RDW": {
|
||||
"clinical_en": "Reflects the heterogeneity of red blood cell volume, that is, the degree of dispersion of red blood cell volume, helping in the differential diagnosis of anemia. The normal RDW - CV (coefficient of variation) is 11.5% - 14.5%.",
|
||||
"clinical_cn": "反映红细胞体积大小的异质性，即红细胞体积的离散程度，帮助贫血的鉴别诊断，正常RDW-CV（变异系数）11.5%-14.5%。"
|
||||
},
|
||||
"RBC MORPHOLOGY": {
|
||||
"clinical_en": "Observing the morphological characteristics of red blood cells (such as normal, spherical, elliptical, sickle - shaped, etc.) is of great value in the diagnosis of the etiology of anemia and hematological diseases. Normal red blood cells are biconcave discs.",
|
||||
"clinical_cn": "观察红细胞的形态特点（如正常、球形、椭圆形、镰状等），对贫血病因、血液系统疾病诊断有重要价值，正常红细胞为双凹圆盘状。"
|
||||
},
|
||||
"WBC COUNT": {
|
||||
"clinical_en": "Reflects the total number of white blood cells, is a preliminary indicator for judging infections, inflammation, and certain blood diseases. The normal range for adults is (3.5 - 9.5) × 10⁹/L. 2.",
|
||||
"clinical_cn": "反映白细胞的总体数量，是判断感染、炎症及某些血液疾病的初步指标，正常成人（3.5-9.5）×10⁹/L。"
|
||||
},
|
||||
"NEUT%": {
|
||||
"clinical_en": "Neutrophils are the main component of white blood cells and play a key role in anti - infection. Changes in their count and percentage reflect infection, inflammation, and hematopoietic conditions. The normal count is (2.0 - 7.5) × 10⁹/L, and the percentage is 50% - 70%.",
|
||||
"clinical_cn": "中性粒细胞是白细胞主要成分，在抗感染中起关键作用，数量和百分比变化反映感染、炎症及造血情况，正常数量（2.0-7.5）×10⁹/L，百分比50%-70%。"
|
||||
},
|
||||
"EOS%": {
|
||||
"clinical_en": "Participates in immune processes such as allergic reactions and anti - parasitic infections. Changes in their count and percentage are significant for the diagnosis of allergic diseases, parasitic infections, etc. The normal count is (0.02 - 0.52) × 10⁹/L, and the percentage is 0.4% - 8%.",
|
||||
"clinical_cn": "参与过敏反应、抗寄生虫感染等免疫过程，数量和百分比变化对过敏疾病、寄生虫感染等诊断有意义，正常数量（0.02-0.52）×10⁹/L，百分比0.4%-8%。"
|
||||
},
|
||||
"BAS%": {
|
||||
"clinical_en": "Participates in allergic reactions and releases bioactive substances (such as histamine). Although their number is small, they are valuable for the diagnosis of allergies and certain blood diseases. The normal count is (0 - 0.06) × 10⁹/L, and the percentage is 0% - 1%.",
|
||||
"clinical_cn": "参与过敏反应，释放生物活性物质（如组胺），数量少但对过敏、某些血液疾病诊断有价值，正常数量（0-0.06）×10⁹/L，百分比0%-1%。"
|
||||
},
|
||||
"LYMPH%": {
|
||||
"clinical_en": "Lymphocytes are an important part of immune cells and participate in specific immunity (such as humoral immunity and cellular immunity). Changes in their count and percentage reflect immune status, infections, and blood diseases, etc. The normal count is (1.1 - 3.2) × 10⁹/L, and the percentage is 20% - 50%.",
|
||||
"clinical_cn": "淋巴细胞是免疫细胞重要组成，参与特异性免疫（如体液免疫、细胞免疫），数量和百分比变化反映免疫状态、感染及血液疾病等，正常数量（1.1-3.2）×10⁹/L，百分比20%-50%。"
|
||||
},
|
||||
"MONO%": {
|
||||
"clinical_en": "Monocytes are precursors of macrophages and play a role in anti - infection and immune regulation, participating in the clearance of pathogens, foreign bodies, etc. The normal count is (0.1 - 0.6) × 10⁹/L, and the percentage is 3% - 10%.",
|
||||
"clinical_cn": "单核细胞是巨噬细胞的前体，在抗感染、免疫调节中起作用，参与清除病原体、异物等，正常数量（0.1-0.6）×10⁹/L，百分比3%-10%。"
|
||||
},
|
||||
"PLT": {
|
||||
"clinical_en": "Reflects the number of platelets, evaluates hemostatic function, and is important for the diagnosis of hemorrhagic diseases, thrombotic diseases, and treatment monitoring. The normal range is (125 - 350) × 10⁹/L.",
|
||||
"clinical_cn": "反映血小板数量，评估止血功能，对出血性疾病、血栓性疾病诊断及治疗监测重要，正常（125-350）×10⁹/L。"
|
||||
},
|
||||
"PCT": {
|
||||
"clinical_en": "Refers to the percentage of volume occupied by platelets in whole blood, related to the number and volume of platelets, assisting in evaluating platelet function and hematopoietic conditions. The normal range is 0.11% - 0.28%.",
|
||||
"clinical_cn": "指血小板在全血中所占体积百分比，与血小板数量、体积有关，辅助评估血小板功能、造血情况，正常0.11%-0.28%。"
|
||||
},
|
||||
"MPV": {
|
||||
"clinical_en": "Reflects the average volume of platelets, which has reference value for platelet function and disease diagnosis. The normal range is 7 - 11fL.",
|
||||
"clinical_cn": "反映血小板的平均体积大小，对血小板功能、疾病诊断有参考价值，正常7-11fL。"
|
||||
},
|
||||
"PDW": {
|
||||
"clinical_en": "Reflects the degree of dispersion of platelet volume, indicating the uniformity of platelet volume, assisting in judging platelet abnormalities. The normal PDW is 15% - 17%.",
|
||||
"clinical_cn": "反映血小板体积大小的离散程度，说明血小板体积的均一性，辅助判断血小板异常，正常PDW15%-17%。"
|
||||
},
|
||||
"FBS": {
|
||||
"clinical_en": "A basic indicator for diagnosing diabetes and evaluating blood sugar control. Normal reference value: 3.9 - 6.1mmol/L.",
|
||||
"clinical_cn": "诊断糖尿病、评估血糖控制的基础指标，正常参考值3.9-6.1mmol/L。"
|
||||
},
|
||||
"HBA1C": {
|
||||
"clinical_en": "Reflects the average blood sugar level in the past 2 - 3 months, evaluating the control effect of diabetes. Normal reference value: 4% - 6%.",
|
||||
"clinical_cn": "反映过去2-3个月平均血糖水平，评估糖尿病控制效果，正常参考值4%-6%。"
|
||||
},
|
||||
"TC": {
|
||||
"clinical_en": "Reflects the overall level of cholesterol in the blood, evaluates the risk of atherosclerosis and cardiovascular diseases. Normal reference value: < 5.2mmol/L (appropriate level), 5.2 - 6.2mmol/L is borderline elevation, > 6.2mmol/L is elevation.",
|
||||
"clinical_cn": "反映血液中胆固醇总体水平，评估动脉粥样硬化、心血管疾病风险，正常参考值＜5.2mmol/L（合适水平），5.2-6.2mmol/L为边缘升高，＞6.2mmol/L为升高。"
|
||||
},
|
||||
"TG": {
|
||||
"clinical_en": "Evaluates dyslipidemia and pancreatitis risk. Normal reference value: < 1.7mmol/L, 1.7 - 2.3mmol/L is borderline elevation, > 2.3mmol/L is elevation.",
|
||||
"clinical_cn": "评估血脂异常、胰腺炎风险，正常参考值＜1.7mmol/L，1.7-2.3mmol/L为边缘升高，＞2.3mmol/L为升高。"
|
||||
},
|
||||
"LP(A)": {
|
||||
"clinical_en": "An independent risk factor for cardiovascular diseases, related to atherosclerosis and thrombosis. Normal reference value: < 300mg/L.",
|
||||
"clinical_cn": "独立的心血管疾病危险因素，与动脉粥样硬化、血栓形成相关，正常参考值＜300mg/L。"
|
||||
},
|
||||
"HDL": {
|
||||
"clinical_en": "\"Good cholesterol\", promotes reverse cholesterol transport, reduces the risk of cardiovascular diseases. Normal reference value: > 1.0mmol/L (males), > 1.3mmol/L (females).",
|
||||
"clinical_cn": "“好胆固醇”，促进胆固醇逆向转运，降低心血管疾病风险，正常参考值＞1.0mmol/L（男性）、＞1.3mmol/L（女性）。"
|
||||
},
|
||||
"LDL": {
|
||||
"clinical_en": "\"Bad cholesterol\", a core factor causing atherosclerosis, a key indicator for evaluating the risk of cardiovascular diseases. Normal reference value: < 3.4mmol/L (appropriate level), 3.4 - 4.1mmol/L is borderline elevation, > 4.1mmol/L is elevation.",
|
||||
"clinical_cn": "“坏胆固醇”，致动脉粥样硬化核心因素，评估心血管疾病风险关键指标，正常参考值＜3.4mmol/L（合适水平），3.4-4.1mmol/L为边缘升高，＞4.1mmol/L为升高。"
|
||||
},
|
||||
"BLOOD TYPE": {
|
||||
"clinical_en": "Used for blood type identification to ensure blood transfusion safety (blood type matching is required during blood transfusion), and also used in fields such as organ transplantation and forensic medicine.",
|
||||
"clinical_cn": "用于血型鉴定，保障输血安全（输血时需血型匹配），也在器官移植、法医学等领域有应用。"
|
||||
},
|
||||
"BLOOD TYPE RH": {
|
||||
"clinical_en": "The RH blood type system is important. Most people are RH positive. RH negative people (\"panda blood\") need special attention during blood transfusion, and it is also related to neonatal hemolytic disease (which may occur when the mother is RH negative and the fetus is RH positive).",
|
||||
"clinical_cn": "RH血型系统重要，大部分人RH阳性，RH阴性者（熊猫血）输血时需特殊注意，也与新生儿溶血病（母亲RH阴性，胎儿RH阳性时可能发生）相关。"
|
||||
},
|
||||
"PT": {
|
||||
"clinical_en": "Reflects the function of the extrinsic coagulation pathway and the common coagulation pathway, used to evaluate vitamin K deficiency, liver disease, oral anticoagulants (such as warfarin), etc. The normal reference value varies depending on the detection method, generally 11 - 13 seconds, and more than 3 seconds longer than the normal control has clinical significance.",
|
||||
"clinical_cn": "反映外源性凝血途径及共同凝血途径的功能，用于评估维生素K缺乏、肝病、口服抗凝剂（如华法林）等情况，正常参考值因检测方法而异，一般11-13秒，超过正常对照3秒有临床意义。"
|
||||
},
|
||||
"APTT": {
|
||||
"clinical_en": "Reflects the function of the intrinsic coagulation pathway and the common coagulation pathway, used to diagnose hemophilia (deficiency of intrinsic coagulation factors), evaluate liver disease, monitor heparin therapy, etc. The normal range is 30 - 45 seconds, and more than 10 seconds longer than the normal control is significant.",
|
||||
"clinical_cn": "反映内源性凝血途径及共同凝血途径的功能，用于诊断血友病（内源性凝血因子缺乏）、评估肝病、监测肝素治疗等，正常30-45秒，超过正常对照10秒有意义。"
|
||||
},
|
||||
"TT": {
|
||||
"clinical_en": "Reflects the process of converting fibrinogen into fibrin, affected by fibrinogen content, structure, and anticoagulants in the blood. The normal range is 16 - 18 seconds, and more than 3 seconds longer than the normal control is significant.",
|
||||
"clinical_cn": "反映纤维蛋白原转化为纤维蛋白的过程，受纤维蛋白原含量、结构及血液中抗凝物质影响，正常16-18秒，超过正常对照3秒有意义。"
|
||||
},
|
||||
"FIB": {
|
||||
"clinical_en": "It is a cross - linked fibrin degradation product, reflecting the body's coagulation and fibrinolytic activity, used to diagnose thrombotic diseases such as DIC, deep vein thrombosis, and pulmonary embolism. The normal reference value is generally < 0.5mg/L (ELISA method), and there are differences in different detection methods.",
|
||||
"clinical_cn": "是交联纤维蛋白降解产物，反映体内凝血和纤溶活性，用于诊断DIC、深静脉血栓、肺栓塞等血栓性疾病，正常参考值一般＜0.5mg/L（ELISA法），不同检测方法有差异。"
|
||||
},
|
||||
"HIV": {
|
||||
"clinical_en": "Used for the screening and diagnosis of AIDS (AIDS), to determine whether HIV is infected. It is normally negative.",
|
||||
"clinical_cn": "用于艾滋病（AIDS）的筛查、诊断，判断是否感染HIV，正常为阴性。"
|
||||
},
|
||||
"TRUST": {
|
||||
"clinical_en": "It is a non - specific antibody test for syphilis, used for syphilis screening and curative effect observation. It is normally negative.",
|
||||
"clinical_cn": "是梅毒非特异性抗体检测，用于梅毒筛查、疗效观察，正常为阴性。"
|
||||
},
|
||||
"TPPA": {
|
||||
"clinical_en": "A test for specific antibodies against Treponema pallidum, used for the diagnosis of syphilis. After syphilis infection, specific antibodies are generally positive for life. It is normally negative.",
|
||||
"clinical_cn": "梅毒螺旋体特异性抗体检测，用于梅毒确诊，感染梅毒后，特异性抗体一般终身阳性，正常为阴性。"
|
||||
},
|
||||
"HBSAG": {
|
||||
"clinical_en": "It is a marker of hepatitis B virus infection, used for hepatitis B screening and diagnosis. It is normally negative.",
|
||||
"clinical_cn": "是乙肝病毒感染的标志，用于乙肝筛查、诊断，正常为阴性。"
|
||||
},
|
||||
"HBSAB": {
|
||||
"clinical_en": "It is a protective antibody against hepatitis B, indicating immunity to hepatitis B virus. It is normally negative or has a protective titer (generally, ≥10mIU/ml is considered to have protective power).",
|
||||
"clinical_cn": "是乙肝保护性抗体，提示对乙肝病毒有免疫力，正常为阴性或有保护性滴度（一般认为≥10mIU/ml有保护力）。"
|
||||
},
|
||||
"HBEAG": {
|
||||
"clinical_en": "Reflects the degree of hepatitis B virus replication and the strength of infectivity. It is normally negative.",
|
||||
"clinical_cn": "反映乙肝病毒复制活跃程度、传染性强弱，正常为阴性。"
|
||||
},
|
||||
"HBEAB": {
|
||||
"clinical_en": "Indicates that hepatitis B virus replication is inhibited and infectivity is reduced. It is normally negative.",
|
||||
"clinical_cn": "表示乙肝病毒复制受抑制，传染性降低，正常为阴性。"
|
||||
},
|
||||
"HBCAB": {
|
||||
"clinical_en": "It is a marker of hepatitis B virus infection. As long as the hepatitis B virus has been infected (whether current infection or past infection), the core antibody is mostly positive. It is normally negative.",
|
||||
"clinical_cn": "是乙肝病毒感染的标志，只要感染过乙肝病毒（无论现症感染还是既往感染），核心抗体多为阳性，正常为阴性。"
|
||||
},
|
||||
"HCV-IGM": {
|
||||
"clinical_en": "Used for the diagnosis and condition monitoring of acute hepatitis C virus (HCV) infection. It is normally negative.",
|
||||
"clinical_cn": "用于丙肝病毒（HCV）急性感染的诊断、病情监测，正常为阴性。"
|
||||
},
|
||||
"KALIUM": {
|
||||
"clinical_en": "Maintains cell physiological functions (such as osmotic pressure, acid - base balance, neuromuscular excitability, etc.), and is particularly important for heart function. The normal serum potassium is 3.5 - 5.5mmol/L.",
|
||||
"clinical_cn": "维持细胞生理功能（如渗透压、酸碱平衡、神经肌肉兴奋性等），对心脏功能尤其重要，正常血清钾3.5-5.5mmol/L。"
|
||||
},
|
||||
"SODIUM": {
|
||||
"clinical_en": "Maintains extracellular fluid osmotic pressure, acid - base balance, participates in nerve conduction, maintains blood volume, etc. The normal serum sodium is 135 - 145mmol/L.",
|
||||
"clinical_cn": "维持细胞外液渗透压、酸碱平衡，参与神经传导、维持血容量等，正常血清钠135-145mmol/L。"
|
||||
},
|
||||
"CHLORIDE": {
|
||||
"clinical_en": "Maintains body fluid osmotic pressure, acid - base balance, participates in gastric acid formation, etc. The normal serum chloride is 96 - 108mmol/L.",
|
||||
"clinical_cn": "维持体液渗透压、酸碱平衡，参与胃酸形成等，正常血清氯96-108mmol/L。"
|
||||
},
|
||||
"CALCIUM": {
|
||||
"clinical_en": "Maintains bone hardness, neuromuscular excitability, coagulation function, etc. The normal total serum calcium is 2.25 - 2.58mmol/L, and ionized calcium is 1.10 - 1.34mmol/L.",
|
||||
"clinical_cn": "维持骨骼硬度、神经肌肉兴奋性、凝血功能等，正常血清总钙2.25-2.58mmol/L，离子钙1.10-1.34mmol/L。"
|
||||
},
|
||||
"MAGNESIUM": {
|
||||
"clinical_en": "Participates in the regulation of various enzyme activities, maintains neuromuscular excitability, heart function, etc. The normal serum magnesium is 0.75 - 1.02mmol/L.",
|
||||
"clinical_cn": "参与多种酶活性调节，维持神经肌肉兴奋性、心脏功能等，正常血清镁0.75-1.02mmol/L。"
|
||||
},
|
||||
"PHOSPHORUS": {
|
||||
"clinical_en": "Participates in bone formation, energy metabolism, nucleic acid synthesis, etc. The normal serum phosphorus is 0.97 - 1.61mmol/L.",
|
||||
"clinical_cn": "参与骨骼形成、能量代谢、核酸合成等，正常血清磷0.97-1.61mmol/L。"
|
||||
},
|
||||
"TP": {
|
||||
"clinical_en": "Reflects liver synthetic function and body protein reserves, assisting in the diagnosis of liver and kidney diseases and nutritional status. Normal reference value: 60 - 80g/L (there may be differences in different detection methods).",
|
||||
"clinical_cn": "反映肝脏合成功能及体内蛋白储备，协助诊断肝肾疾病、营养状态。正常参考值：60-80g/L（不同检测方法可能有差异）。"
|
||||
},
|
||||
"A": {
|
||||
"clinical_en": "The main protein synthesized by the liver, reflecting liver synthetic capacity and nutritional status, and maintaining plasma colloid osmotic pressure. Normal reference value: 40 - 55g/L.",
|
||||
"clinical_cn": "肝脏合成的主要蛋白，体现肝脏合成能力、营养状态，维持血浆胶体渗透压。正常参考值：40-55g/L。"
|
||||
},
|
||||
"G": {
|
||||
"clinical_en": "Participates in immunity, reflects the body's immune status, and together with albumin, judges liver diseases and immune diseases. Normal reference value: 20 - 30g/L.",
|
||||
"clinical_cn": "参与免疫，反映机体免疫状态，与白蛋白协同判断肝脏疾病、免疫疾病。正常参考值：20-30g/L。"
|
||||
},
|
||||
"A/G": {
|
||||
"clinical_en": "Evaluates liver function and protein metabolism balance. The normal ratio is 1.5 - 2.5:1.",
|
||||
"clinical_cn": "评估肝脏功能、蛋白代谢平衡，正常比值1.5-2.5:1。"
|
||||
},
|
||||
"TBIL": {
|
||||
"clinical_en": "Reflects hepatocyte damage and bile excretion, assisting in the diagnosis of jaundice types (hemolytic, hepatocellular, obstructive). Normal reference value: 3.4 - 17.1μmol/L.",
|
||||
"clinical_cn": "反映肝细胞损伤、胆汁排泄情况，协助诊断黄疸类型（溶血性、肝细胞性、梗阻性）。正常参考值：3.4-17.1μmol/L。"
|
||||
},
|
||||
"DBIL": {
|
||||
"clinical_en": "Also known as conjugated bilirubin, reflects hepatocyte processing of bilirubin and biliary excretion function, assisting in jaundice identification. Normal reference value: 0 - 6.8μmol/L.",
|
||||
"clinical_cn": "又称结合胆红素，反映肝细胞处理胆红素及胆道排泄功能，辅助黄疸鉴别。正常参考值：0-6.8μmol/L。"
|
||||
},
|
||||
"IBIL": {
|
||||
"clinical_en": "Also known as unconjugated bilirubin, reflects red blood cell destruction and the liver's initial metabolic capacity, assisting in jaundice identification. Normal reference value: 3.4 - 10.2μmol/L (calculated by TBi - DBi).",
|
||||
"clinical_cn": "又称非结合胆红素，反映红细胞破坏及肝脏初步代谢能力，辅助黄疸鉴别。正常参考值：3.4-10.2μmol/L（TBi-DBi计算得）。"
|
||||
},
|
||||
"ALP": {
|
||||
"clinical_en": "Reflects hepatocyte damage and biliary obstruction, and is also used to diagnose bone metabolic diseases (such as rickets, bone tumors). Normal reference value: 45 - 125U/L (adults); children and adolescents may have higher values due to bone development.",
|
||||
"clinical_cn": "反映肝细胞损伤、胆道梗阻，也用于诊断骨代谢疾病（如佝偻病、骨肿瘤）。正常参考值：45-125U/L（成人）；儿童、青少年因骨骼发育，数值可更高。"
|
||||
},
|
||||
"ALT": {
|
||||
"clinical_en": "A sensitive indicator of hepatocyte damage, which increases in the early stage of hepatitis, drug - induced liver injury, etc. Normal reference value: 7 - 40U/L (there may be differences in different reagents).",
|
||||
"clinical_cn": "肝细胞损伤敏感指标，肝炎、药物肝损伤等早期即升高。正常参考值：7-40U/L（不同试剂有差异）。"
|
||||
},
|
||||
"AST": {
|
||||
"clinical_en": "An indicator of myocardial, liver, and skeletal muscle damage. It increases in myocardial infarction, and can also be abnormal in liver diseases and muscle diseases. Normal reference value: 13 - 35U/L.",
|
||||
"clinical_cn": "心肌、肝脏、骨骼肌损伤指标，心肌梗死时升高，肝病、肌肉疾病也可异常。正常参考值：13-35U/L。"
|
||||
},
|
||||
"GGT": {
|
||||
"clinical_en": "Reflects hepatocyte damage and biliary obstruction, and is of auxiliary value in the diagnosis of alcoholic liver disease and liver cancer. Normal reference value: 7 - 45U/L (adults).",
|
||||
"clinical_cn": "反映肝细胞损伤、胆道梗阻，对酒精性肝病、肝癌诊断有辅助价值。正常参考值：7-45U/L（成人）。"
|
||||
},
|
||||
"SCR": {
|
||||
"clinical_en": "Reflects glomerular filtration function, evaluates the degree of renal function damage (one of the bases for chronic renal failure staging). Normal reference value: 53 - 106μmol/L for males, 44 - 97μmol/L for females (due to differences in muscle mass).",
|
||||
"clinical_cn": "反映肾小球滤过功能，评估肾功能损伤程度（慢性肾衰分期依据之一）。正常参考值：男性53-106μmol/L，女性44-97μmol/L（因肌肉量有差异）。"
|
||||
},
|
||||
"BUN": {
|
||||
"clinical_en": "Reflects glomerular filtration function and protein metabolism status (greatly affected by diet and extrarenal factors). Normal reference value: 3.2 - 7.1mmol/L.",
|
||||
"clinical_cn": "反映肾小球滤过功能、蛋白质代谢状态（受饮食、肾外因素影响大）。正常参考值：3.2-7.1mmol/L。"
|
||||
},
|
||||
"UA": {
|
||||
"clinical_en": "Reflects the end product of purine metabolism and renal excretion. Elevated levels (hyperuricemia) are associated with gout, kidney stones, metabolic syndrome, hypertension, and cardiovascular disease.",
|
||||
"clinical_cn": "反映嘌呤代谢终产物及肾脏排泄功能。升高（高尿酸血症）常与痛风、肾结石、代谢综合征、高血压及心血管疾病相关。"
|
||||
},
|
||||
"CK": {
|
||||
"clinical_en": "A specific indicator of myocardial and skeletal muscle damage, early diagnosis of myocardial infarction (increases 4 - 6h, peaks 1 - 2 days), and also used to diagnose myopathy (such as myositis, progressive muscular dystrophy). Normal reference value: 50 - 310U/L for males, 40 - 200U/L for females.",
|
||||
"clinical_cn": "心肌、骨骼肌损伤特异性指标，心肌梗死早期诊断（4-6h升高，1-2天达峰），也用于诊断肌病（如肌炎、进行性肌营养不良）。正常参考值：男性50-310U/L，女性40-200U/L。"
|
||||
},
|
||||
"LDH": {
|
||||
"clinical_en": "An indicator of myocardial, liver, skeletal muscle, and hematological system diseases. It can increase in myocardial infarction (increases 12 - 24h, recovers 1 - 2 weeks), liver diseases, and hemolytic anemia. Normal reference value: 120 - 250U/L.",
|
||||
"clinical_cn": "心肌、肝脏、骨骼肌、血液系统疾病指标，心肌梗死（12-24h升高，1-2周恢复）、肝病、溶血性贫血均可升高。正常参考值：120-250U/L。"
|
||||
},
|
||||
"CK-MB": {
|
||||
"clinical_en": "A specific indicator of myocardial damage, early diagnosis of myocardial infarction (increases 3 - 4h, peaks 1 - 2 days), better than total CK. Normal reference value: 0 - 25U/L (activity method); < 4ng/ml (mass method, more accurate).",
|
||||
"clinical_cn": "心肌损伤特异性指标，心肌梗死早期诊断（3-4h升高，1-2天达峰），优于总CK。正常参考值：0-25U/L（活性法）；＜4ng/ml（质量法，更精准）。"
|
||||
},
|
||||
"T3": {
|
||||
"clinical_en": "Reflects thyroid function, increases in hyperthyroidism and decreases in hypothyroidism, and is also used to evaluate the severity of the disease (such as significantly high T3 in thyroid storm). Normal reference value: 1.3 - 3.1nmol/L.",
|
||||
"clinical_cn": "反映甲状腺功能，甲亢时升高、甲减时降低，也用于评估病情严重度（如甲亢危象T3显著高）。正常参考值：1.3-3.1nmol/L。"
|
||||
},
|
||||
"T4": {
|
||||
"clinical_en": "Reflects thyroid function, increases in hyperthyroidism and decreases in hypothyroidism. Because T4 has a long half - life, it more stably reflects thyroid reserve function. Normal reference value: 12 - 22pmol/L.",
|
||||
"clinical_cn": "反映甲状腺功能，甲亢时升高、甲减时降低，因T4半衰期长，更稳定反映甲状腺储备功能。正常参考值：12-22pmol/L。"
|
||||
},
|
||||
"FT3": {
|
||||
"clinical_en": "Reflects the \"active indicator\" of thyroid function, not affected by binding proteins, more accurately diagnosing hyperthyroidism / hypothyroidism. Normal reference value: 3.1 - 6.8pmol/L.",
|
||||
"clinical_cn": "反映甲状腺功能的“活性指标”，不受结合蛋白影响，更精准诊断甲亢/甲减。正常参考值：3.1-6.8pmol/L。"
|
||||
},
|
||||
"FT4": {
|
||||
"clinical_en": "The \"active indicator\" of thyroid function, stably reflects thyroid hormone levels, and is a core indicator for the diagnosis and efficacy monitoring of hyperthyroidism / hypothyroidism. Normal reference value: 12 - 22pmol/L.",
|
||||
"clinical_cn": "甲状腺功能“活性指标”，稳定反映甲状腺激素水平，甲亢/甲减诊断、疗效监测核心指标。正常参考值：12-22pmol/L。"
|
||||
},
|
||||
"TSH": {
|
||||
"clinical_en": "Reflects the function of the pituitary - thyroid axis, decreases in hyperthyroidism and increases in hypothyroidism, and is the preferred screening indicator for hypothyroidism (sensitive). Normal reference value: 0.27 - 4.2mIU/L.",
|
||||
"clinical_cn": "反映垂体-甲状腺轴功能，甲亢时降低、甲减时升高，是甲减首选筛查指标（敏感）。正常参考值：0.27-4.2mIU/L。"
|
||||
},
|
||||
"HOMOCYSTEINE": {
|
||||
"clinical_en": "An independent risk factor for cardiovascular and cerebrovascular diseases, elevation increases the risk of atherosclerosis, cerebral infarction, and coronary heart disease. Normal reference value: 5 - 15μmol/L.",
|
||||
"clinical_cn": "心脑血管疾病独立危险因素，升高增加动脉粥样硬化、脑梗死、冠心病风险，正常参考值5-15μmol/L。"
|
||||
},
|
||||
"D-DIMER": {
|
||||
"clinical_en": "(mentioned in the four coagulation items above, focusing on cardiovascular and cerebrovascular risks here) Reflects the body's coagulation and fibrinolytic activity, assisting in the diagnosis of pulmonary embolism, deep vein thrombosis, etc. The normal reference value is < 0.5mg/L (ELISA method).",
|
||||
"clinical_cn": "反映体内凝血和纤溶活性，辅助诊断肺栓塞、深静脉血栓等，正常参考值＜0.5mg/L。"
|
||||
},
|
||||
"25-OH-VD2+D3": {
|
||||
"clinical_en": "Reflects the body’s vitamin D status and calcium-phosphorus metabolism. It is the most reliable marker for evaluating vitamin D reserves. Deficiency is associated with rickets, osteomalacia, osteoporosis, and increased risks of fractures and certain chronic diseases. The optimal reference range is usually 30–100 ng/mL, with <20 ng/mL indicating deficiency.",
|
||||
"clinical_cn": "反映机体维生素D水平及钙磷代谢状态，是评估维生素D储备最可靠的指标。缺乏与佝偻病、骨软化症、骨质疏松及骨折风险增加等相关，也可能与部分慢性疾病发生率升高有关。正常参考范围通常为 30–100 ng/mL，＜20 ng/mL 提示缺乏。"
|
||||
},
|
||||
"PTH": {
|
||||
"clinical_en": "Regulates calcium and phosphorus metabolism, maintains blood calcium stability, and diagnoses hyperparathyroidism / hypoparathyroidism. Normal reference value: 15 - 65pg/ml.",
|
||||
"clinical_cn": "调节钙磷代谢，维持血钙稳定，诊断甲状旁腺功能亢进/减退，正常参考值15-65pg/ml。"
|
||||
},
|
||||
"OST": {
|
||||
"clinical_en": "Serves as a sensitive marker of bone formation and osteoblastic activity. Elevated levels suggest active bone metabolism (e.g., during growth or fracture healing), while reduced levels may indicate impaired bone formation, osteoporosis, or metabolic bone disease. It is also used to monitor the efficacy of anti-osteoporosis treatments.",
|
||||
"clinical_cn": "是反映骨形成和成骨细胞活性的敏感指标。升高提示骨代谢活跃（如儿童生长期或骨折愈合期），降低则可能提示骨形成不足、骨质疏松或代谢性骨病。常用于骨质疏松治疗过程中的疗效监测。"
|
||||
},
|
||||
"TPINP": {
|
||||
"clinical_en": "A bone formation marker, reflecting the synthesis of type I collagen, evaluating bone metabolism and the effect of osteoporosis treatment. The normal reference value varies depending on the detection method, generally 14 - 42ng/ml for adult males, 10 - 35ng/ml for premenopausal females, and 19 - 71ng/ml for postmenopausal females.",
|
||||
"clinical_cn": "骨形成标志物，反映I型胶原合成情况，评估骨代谢、骨质疏松治疗效果，正常参考值因检测方法而异，一般成人男性14-42ng/ml，女性绝经前10-35ng/ml，绝经后19-71ng/ml。"
|
||||
},
|
||||
"Β-CTX": {
|
||||
"clinical_en": "A bone resorption marker, reflecting bone collagen degradation, evaluating osteoporosis and bone turnover rate. The normal reference value is 0.13 - 0.47ng/ml for adult males, 0.11 - 0.43ng/ml for premenopausal females, and 0.23 - 0.78ng/ml for postmenopausal females.",
|
||||
"clinical_cn": "骨吸收标志物，反映骨胶原降解情况，评估骨质疏松、骨转换率，正常参考值成人男性0.13-0.47ng/ml，女性绝经前0.11-0.43ng/ml，绝经后0.23-0.78ng/ml。"
|
||||
},
|
||||
"PB": {
|
||||
"clinical_en": "Evaluates lead exposure and lead poisoning risk. Excessive lead can damage the nervous system, blood system, digestive system, etc.",
|
||||
"clinical_cn": "评估铅暴露及铅中毒风险，铅过量会损害神经系统、血液系统、消化系统等。"
|
||||
},
|
||||
"CU": {
|
||||
"clinical_en": "Participates in the synthesis of various enzymes (such as ceruloplasmin, superoxide dismutase), evaluates nutritional status, liver diseases, and genetic metabolic diseases (such as Wilson's disease).",
|
||||
"clinical_cn": "参与多种酶（如铜蓝蛋白、超氧化物歧化酶）合成，评估营养状态、肝脏疾病、遗传代谢病（如肝豆状核变性）。"
|
||||
},
|
||||
"ZN": {
|
||||
"clinical_en": "Participates in growth and development, immune function, and substance metabolism, evaluates nutritional status, immune diseases, and hereditary zinc deficiency diseases.",
|
||||
"clinical_cn": "参与生长发育、免疫功能、物质代谢，评估营养状态、免疫疾病、遗传性锌缺乏病。"
|
||||
},
|
||||
"MG": {
|
||||
"clinical_en": "Participates in enzyme activity, neuromuscular function, and bone metabolism, evaluates electrolyte balance and nutritional status.",
|
||||
"clinical_cn": "参与酶活性、神经肌肉功能、骨代谢，评估电解质平衡、营养状态。"
|
||||
},
|
||||
"FE": {
|
||||
"clinical_en": "Participates in hemoglobin synthesis and oxygen transport, evaluates iron - deficiency anemia and iron overload (such as hemochromatosis).",
|
||||
"clinical_cn": "参与血红蛋白合成、氧运输，评估缺铁性贫血、铁过载（如血色病）。"
|
||||
},
|
||||
"CD3+": {
|
||||
"clinical_en": "Reflects the total number of T cells, evaluates cellular immune function, and assists in the diagnosis of immunodeficiency diseases, autoimmune diseases, and tumor immune status.",
|
||||
"clinical_cn": "反映总T细胞数量，评估细胞免疫功能，辅助诊断免疫缺陷病、自身免疫病、肿瘤免疫状态。"
|
||||
},
|
||||
"CD4+": {
|
||||
"clinical_en": "Assists in immune response, is a core indicator for AIDS diagnosis and condition monitoring, and is also used to evaluate autoimmune diseases and tumor immune status.",
|
||||
"clinical_cn": "辅助免疫应答，是艾滋病诊断、病情监测核心指标，也用于评估自身免疫病、肿瘤免疫状态。"
|
||||
},
|
||||
"CD8+": {
|
||||
"clinical_en": "Reflects the clarity and transparency of urine, assisting in judging abnormal components in the urine. Normal urine is clear and transparent, and abnormal turbidity is related to the presence of cells, crystals, bacteria, etc. in the urine.",
|
||||
"clinical_cn": "杀伤感染细胞、肿瘤细胞，评估免疫功能、肿瘤免疫监视、病毒感染状态。"
|
||||
},
|
||||
"IGG": {
|
||||
"clinical_en": "The most abundant immunoglobulin in the body, involved in anti-infection and autoimmune regulation; used to assess humoral immune function, diagnose autoimmune diseases, and infectious diseases.",
|
||||
"clinical_cn": "体内含量最高的免疫球蛋白，参与抗感染、自身免疫调节，评估体液免疫功能、诊断自身免疫病、感染性疾病。"
|
||||
},
|
||||
"IGA": {
|
||||
"clinical_en": "Participates in mucosal immunity (respiratory and gastrointestinal tracts); used for evaluating infections, autoimmune diseases, and allergic disorders.",
|
||||
"clinical_cn": "参与黏膜免疫（如呼吸道、消化道），评估感染、自身免疫病、过敏性疾病。"
|
||||
},
|
||||
"IGM": {
|
||||
"clinical_en": "An early-response immunoglobulin during acute infection; used to evaluate acute infections, autoimmune diseases, and hematological disorders (e.g., Waldenström’s macroglobulinemia).",
|
||||
"clinical_cn": "感染早期快速应答的免疫球蛋白，评估急性感染、自身免疫病、血液病（如巨球蛋白血症）。"
|
||||
},
|
||||
"IGE": {
|
||||
"clinical_en": "Involved in allergic diseases and immune response against parasitic infections; used to assess allergic status and parasitic diseases.",
|
||||
"clinical_cn": "参与过敏性疾病、寄生虫感染免疫应答，评估过敏状态、寄生虫病。"
|
||||
},
|
||||
"C3": {
|
||||
"clinical_en": "A central component of the complement system; plays a role in immune defense and regulation; used in evaluating autoimmune diseases, infectious diseases, and renal disorders.",
|
||||
"clinical_cn": "补体系统核心成分，参与免疫防御、免疫调节，评估自身免疫病、感染性疾病、肾脏疾病。"
|
||||
},
|
||||
"C4": {
|
||||
"clinical_en": "Involved in activation of the classical complement pathway; aids in the diagnosis of autoimmune diseases (e.g., systemic lupus erythematosus) and hereditary complement deficiencies.",
|
||||
"clinical_cn": "参与补体经典途径激活，辅助诊断自身免疫病（如系统性红斑狼疮）、遗传性补体缺陷病。"
|
||||
},
|
||||
"CRP": {
|
||||
"clinical_en": "An acute-phase protein; rapidly assesses infection, inflammation, and tissue injury.",
|
||||
"clinical_cn": "急性时相反应蛋白，快速评估感染、炎症、组织损伤程度。"
|
||||
},
|
||||
"ESR": {
|
||||
"clinical_en": "Indirectly reflects inflammation, tissue damage, and anemia; assists in diagnosing infections, autoimmune diseases, and malignancies.",
|
||||
"clinical_cn": "间接反映炎症、组织损伤、贫血等，辅助诊断感染、自身免疫病、肿瘤。"
|
||||
},
|
||||
"ASO": {
|
||||
"clinical_en": "Used to diagnose Group A β-hemolytic streptococcal infections (e.g., scarlet fever, rheumatic fever, acute glomerulonephritis); reflects recent infection history.",
|
||||
"clinical_cn": "诊断A组溶血性链球菌感染（如猩红热、风湿热、急性肾小球肾炎），评估近期感染史。"
|
||||
},
|
||||
"ANA": {
|
||||
"clinical_en": "A screening marker for autoimmune diseases (particularly connective tissue diseases); used in evaluating systemic lupus erythematosus, rheumatoid arthritis, and Sjögren’s syndrome.",
|
||||
"clinical_cn": "自身免疫病（尤其是结缔组织病）的筛查指标，评估系统性红斑狼疮、类风湿关节炎、干燥综合征等。"
|
||||
},
|
||||
"RF": {
|
||||
"clinical_en": "Helps in diagnosing rheumatoid arthritis; used to assess disease activity and prognosis.",
|
||||
"clinical_cn": "辅助诊断类风湿关节炎，评估疾病活动度、预后。"
|
||||
},
|
||||
"NEUT": {
|
||||
"clinical_en": "Neutrophils are the main component of white blood cells and play a key role in anti - infection. Changes in their count and percentage reflect infection, inflammation, and hematopoietic conditions. The normal count is (2.0 - 7.5) × 10⁹/L, and the percentage is 50% - 70%.",
|
||||
"clinical_cn": "中性粒细胞是白细胞主要成分，在抗感染中起关键作用，数量和百分比变化反映感染、炎症及造血情况，正常数量（2.0-7.5）×10⁹/L，百分比50%-70%。"
|
||||
},
|
||||
"EOS": {
|
||||
"clinical_en": "Participates in immune processes such as allergic reactions and anti - parasitic infections. Changes in their count and percentage are significant for the diagnosis of allergic diseases, parasitic infections, etc. The normal count is (0.02 - 0.52) × 10⁹/L, and the percentage is 0.4% - 8%.",
|
||||
"clinical_cn": "参与过敏反应、抗寄生虫感染等免疫过程，数量和百分比变化对过敏疾病、寄生虫感染等诊断有意义，正常数量（0.02-0.52）×10⁹/L，百分比0.4%-8%。"
|
||||
},
|
||||
"BAS": {
|
||||
"clinical_en": "Participates in allergic reactions and releases bioactive substances (such as histamine). Although their number is small, they are valuable for the diagnosis of allergies and certain blood diseases. The normal count is (0 - 0.06) × 10⁹/L, and the percentage is 0% - 1%.",
|
||||
"clinical_cn": "参与过敏反应，释放生物活性物质（如组胺），数量少但对过敏、某些血液疾病诊断有价值，正常数量（0-0.06）×10⁹/L，百分比0%-1%。"
|
||||
},
|
||||
"LYMPH": {
|
||||
"clinical_en": "Lymphocytes are an important part of immune cells and participate in specific immunity (such as humoral immunity and cellular immunity). Changes in their count and percentage reflect immune status, infections, and blood diseases, etc. The normal count is (1.1 - 3.2) × 10⁹/L, and the percentage is 20% - 50%.",
|
||||
"clinical_cn": "淋巴细胞是免疫细胞重要组成，参与特异性免疫（如体液免疫、细胞免疫），数量和百分比变化反映免疫状态、感染及血液疾病等，正常数量（1.1-3.2）×10⁹/L，百分比20%-50%。"
|
||||
},
|
||||
"MONO": {
|
||||
"clinical_en": "Monocytes are precursors of macrophages and play a role in anti - infection and immune regulation, participating in the clearance of pathogens, foreign bodies, etc. The normal count is (0.1 - 0.6) × 10⁹/L, and the percentage is 3% - 10%.",
|
||||
"clinical_cn": "单核细胞是巨噬细胞的前体，在抗感染、免疫调节中起作用，参与清除病原体、异物等，正常数量（0.1-0.6）×10⁹/L，百分比3%-10%。"
|
||||
}
|
||||
}
|
||||
Reference in New Issue
Block a user